Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to preve…
Moraes Ribeiro E; Secker KA; Nitulescu AM; Schairer R; Keppeler H; Wesle A; Schmid H; Schmitt A; Neuber B; Chmiest D; Podavini S; Märklin M; Klimovich B; Schmitt M; Korkmaz F; Lengerke C; Schneidawind C; Schneidawind D.
J Immunother Cancer
(Unknown)
Published: 2024
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series.
Harvey C; Nahar KJ; McKeown J; Lo SN; Farag S; Yousaf N; Young K; Tas L; Meerveld-Eggink A; Blank C; Thomas A; McQuade J; Schilling B; Johnson DB; Huertas RM; Arance A; Lee J; Zimmer L; Long GV; Carlino MS; Wang Y; Menzies AM.
J Immunother Cancer
(Unknown)
Published: 2024
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, an…
Desroys du Roure P; Lajoie L; Mallavialle A; Alcaraz LB; Mansouri H; Fenou L; Garambois V; Rubio L; David T; Coenon L; Boissière-Michot F; Chateau MC; Ngo G; Jarlier M; Villalba M; Martineau P; Laurent-Matha V; Roger P; Guiu S; Chardès T; Gros L; Liaudet-Coopman E.
J Immunother Cancer
(Unknown)
Published: 2024
Multimodal profiling of chordoma immunity reveals distinct immune contextures.
van Oost S; Meijer DM; Ijsselsteijn ME; Roelands JP; van den Akker BEMW; van der Breggen R; Briaire-de Bruijn IH; van der Ploeg M; Wijers-Koster PM; Polak SB; Peul WC; van der Wal RJP; de Miranda NFCC; Bovee JVMG.
J Immunother Cancer
(Unknown)
Published: 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial an…
Huffman BM; Singh H; Ali LR; Horick N; Wang SJ; Hoffman MT; Metayer KA; Murray S; Bird A; Abrams TA; Biller LH; Chan JA; Meyerhardt JA; McCleary NJ; Goessling W; Patel AK; Wisch JS; Yurgelun MB; Mouw K; Reardon B; Van Allen EM; Zerillo JA; Clark JW; Parikh A; Mayer RJ; Schlechter B; Ng K; Kumar S; Del Vecchio Fitz C; Kuperwasser C; Hanna GJ; Coveler AL; Rubinson DA; Welsh EL; Pfaff K; Rodig S; Dougan SK; Cleary JM.
J Immunother Cancer
(Unknown)
Published: 2024
Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4<sup>+</sup> naïve T cells…
Kovacsovics-Bankowski M; Sweere JM; Healy CP; Sigal N; Cheng LC; Chronister WD; Evans SA; Marsiglio J; Gibson B; Swami U; Erickson-Wayman A; McPherson JP; Derose YS; Eliason AL; Medina CO; Srinivasan R; Spitzer MH; Nguyen N; Hyngstrom J; Hu-Lieskovan S.
J Immunother Cancer
(Unknown)
Published: 2024
<i>CCR5</i> and <i>CCL5</i> gene expression in colorectal cancer: comprehensive profiling and clinical value.
Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ.
J Immunother Cancer
(Unknown)
Published: 2024
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a pros…
Penack O; Luft T; Peczynski C; Benner A; Sica S; Arat M; Itäla-Remes M; Corral LL; Schaap NPM; Karas M; Raida L; Schroeder T; Dreger P; Metafuni E; Ozcelik T; Sandmaier BM; Kordelas L; Moiseev I; Schoemans H; Koenecke C; Basak GW; Peric Z.
J Immunother Cancer
(Unknown)
Published: 2024